Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for 22nd Century Group, Inc (XXII : NSDQ)
 
 • Company Description   
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.

Number of Employees: 32

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.60 Daily Weekly Monthly
20 Day Moving Average: 3,966,624 shares
Shares Outstanding: 4.46 (millions)
Market Capitalization: $2.66 (millions)
Beta: 0.77
52 Week High: $327.75
52 Week Low: $0.51
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -65.09% -66.79%
12 Week -87.92% -88.83%
Year To Date -94.83% -95.23%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
321 Farmington Road
-
Mocksville,NC 27028
USA
ph: 336-940-3769
fax: 716-877-3064
mkreps@xxiicentury.com http://www.xxiicentury.com
 
 • General Corporate Information   
Officers
Lawrence D. Firestone - Chief Executive Officer
Daniel Otto - Chief Financial Officer
Andrew Arno - Director
David Keys - Director
Lucille S. Salhany - Director

Peer Information
22nd Century Group, Inc (SOZCF)
22nd Century Group, Inc (ISPR)
22nd Century Group, Inc (CIGR)
22nd Century Group, Inc (STW.)
22nd Century Group, Inc (SWMA.)
22nd Century Group, Inc (UST.)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: TOBACCO
Sector: Consumer Staples
CUSIP: 90137F608
SIC: 2111
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/13/26
Share - Related Items
Shares Outstanding: 4.46
Most Recent Split Date: 1.00 (0.07:1)
Beta: 0.77
Market Capitalization: $2.66 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/13/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.13
Price/Cash Flow: -
Price / Sales: 0.17
EPS Growth
vs. Year Ago Period: 99.22%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -31.08%
vs. Previous Quarter: 16.06%
ROE
03/31/26 - -84.37
12/31/25 - -120.94
09/30/25 - -184.33
ROA
03/31/26 - -45.90
12/31/25 - -50.83
09/30/25 - -59.58
Current Ratio
03/31/26 - 2.67
12/31/25 - 2.42
09/30/25 - 2.17
Quick Ratio
03/31/26 - 2.12
12/31/25 - 1.83
09/30/25 - 1.90
Operating Margin
03/31/26 - -81.74
12/31/25 - -74.58
09/30/25 - -80.68
Net Margin
03/31/26 - -25.34
12/31/25 - -28.74
09/30/25 - -37.64
Pre-Tax Margin
03/31/26 - -81.91
12/31/25 - -74.74
09/30/25 - -80.85
Book Value
03/31/26 - 4.76
12/31/25 - 30.89
09/30/25 - 39.42
Inventory Turnover
03/31/26 - 5.37
12/31/25 - 6.74
09/30/25 - 8.67
Debt-to-Equity
03/31/26 - 0.02
12/31/25 - 0.03
09/30/25 - 0.00
Debt-to-Capital
03/31/26 - 2.19
12/31/25 - 2.65
09/30/25 - 0.00
 

Powered by Zacks Investment Research ©